Susanna Naggie, MD
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) (NCT05894577) | Susanna Naggie, MD | 2023-01-27 |
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) (NCT05894564) | Susanna Naggie, MD | 2022-08-25 |
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) (NCT05894538) | Susanna Naggie, MD | 2022-02-16 |
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) (NCT05736874) | Susanna Naggie, MD | 2021-08-06 |
| ACTIV-6: COVID-19 Study of Repurposed Medications (NCT04885530) | Susanna Naggie, MD | 2021-06-08 |
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) (NCT05890586) | Susanna Naggie, MD | 2021-06-08 |
| ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) (NCT05736861) | Susanna Naggie, MD | 2021-06-08 |
Track Susanna Naggie, MD automatically
Every clearance here is in the API, with alerts when new ones post.